A phase 3 trial of Intec Pharma’s Parkinson's disease drug has missed its primary endpoint, sparking a steep decline in the company’s stock. The candidate uses a drug delivery system designed to ...
Evidence that Parkinson’s drug levodopa may cause freezing of gait should be addressed with new studies that investigate a possible shift to alternative dosing strategies or treatment options. That’s ...
Such orders sinemet drugs are conjugated in the liver and passed into bile before they reach the systemic circulation. Often bacteria in the large intestine digest the conjugate releasing free drug, ...
Dopa-decarboxylase inhibitor + dopamine precursor. ≥18yrs: Do not crush or chew. Patients not receiving levodopa: initially one Sinemet CR 50–200 tab twice daily, at intervals of at least 6 hrs.
DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The "Global Parkinson's Drug Market & Clinical Trial Insight 2025" clinical trials has been added to ResearchAndMarkets.com's offering. This report, Global ...
AbbVie's Duopa successor in Parkinson's rejected again after FDA flags 3rd-party manufacturer issues
A little over a year after being slapped with an FDA rejection, AbbVie has hit another regulatory wall in its bid to debut a more convenient Parkinson’s disease successor to its established ...
The US Food and Drug Administration (FDA) has approved foscarbidopa and foslevodopa (Vyalev, AbbVie), a solution of carbidopa and levodopa prodrugs for 24-hour continuous subcutaneous infusion, for ...
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a ...
Rytary is also used to treat PD in adults. To learn more about Rytary’s uses, see “Is Rytary used for Parkinson’s disease?” and “Is Rytary used for other conditions?” below. Rytary comes as a capsule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback